This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Mar;44(3):271-3.

doi: 10.1093/rheumatology/keh483. Epub 2004 Nov 23.

Anti-TNF-alpha therapies: they are all the same (aren't they?)

S Mpofu¹, F Fatima, R J Moots

Affiliations

PMID: 15561736
DOI: 10.1093/rheumatology/keh483

Review

Anti-TNF-alpha therapies: they are all the same (aren't they?)

S Mpofu et al. Rheumatology (Oxford). 2005 Mar.

. 2005 Mar;44(3):271-3.

doi: 10.1093/rheumatology/keh483. Epub 2004 Nov 23.

Authors

S Mpofu¹, F Fatima, R J Moots

Affiliation

¹ Academic Rheumatology Unit, University of Liverpool, Clinical Sciences Center, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK.

PMID: 15561736
DOI: 10.1093/rheumatology/keh483

No abstract available

PubMed Disclaimer

Similar articles

New drugs for rheumatoid arthritis.
Olsen NJ, Stein CM. Olsen NJ, et al. N Engl J Med. 2004 May 20;350(21):2167-79. doi: 10.1056/NEJMra032906. N Engl J Med. 2004. PMID: 15152062 Review. No abstract available.
Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL, Silman AJ. Hyrich KL, et al. J Rheumatol. 2006 May;33(5):831-3. J Rheumatol. 2006. PMID: 16652412 No abstract available.
Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J. van der Stoep D, et al. J Rheumatol. 2009 Dec;36(12):2847-8. doi: 10.3899/jrheum.090307. J Rheumatol. 2009. PMID: 19966199 No abstract available.
Tumor necrosis factor inhibitors for rheumatoid arthritis.
Scott DL, Kingsley GH. Scott DL, et al. N Engl J Med. 2006 Aug 17;355(7):704-12. doi: 10.1056/NEJMct055183. N Engl J Med. 2006. PMID: 16914706 Review. No abstract available.
Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
Gabriel SE. Gabriel SE. Arthritis Rheum. 2008 Mar;58(3):637-40. doi: 10.1002/art.23280. Arthritis Rheum. 2008. PMID: 18311805 No abstract available.

See all similar articles

Cited by

Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders.
Gonzalez Caldito N. Gonzalez Caldito N. Front Immunol. 2023 Jul 7;14:1213448. doi: 10.3389/fimmu.2023.1213448. eCollection 2023. Front Immunol. 2023. PMID: 37483590 Free PMC article. Review.
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.
Bianchi A, De Castro Silva I, Deshpande NU, Singh S, Mehra S, Garrido VT, Guo X, Nivelo LA, Kolonias DS, Saigh SJ, Wieder E, Rafie CI, Dosch AR, Zhou Z, Umland O, Amirian H, Ogobuiro IC, Zhang J, Ban Y, Shiau C, Nagathihalli NS, Montgomery EA, Hwang WL, Brambilla R, Komanduri K, Villarino AV, Toska E, Stanger BZ, Gabrilovich DI, Merchant NB, Datta J. Bianchi A, et al. Cancer Discov. 2023 Jun 2;13(6):1428-1453. doi: 10.1158/2159-8290.CD-22-1046. Cancer Discov. 2023. PMID: 36946782 Free PMC article.
Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis.
Min HK, Kim SH, Kim HR, Lee SH. Min HK, et al. Int J Mol Sci. 2022 Nov 11;23(22):13913. doi: 10.3390/ijms232213913. Int J Mol Sci. 2022. PMID: 36430392 Free PMC article. Review.
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy.
Valenzuela-Cardenas M, Gowan C, Dryja P, Bartee MY, Bartee E. Valenzuela-Cardenas M, et al. J Immunother Cancer. 2022 May;10(5):e004770. doi: 10.1136/jitc-2022-004770. J Immunother Cancer. 2022. PMID: 35577502 Free PMC article.
Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor.
Chey SY, Kermode AG. Chey SY, et al. Mult Scler J Exp Transl Clin. 2022 Jan 5;8(1):20552173211070750. doi: 10.1177/20552173211070750. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35024163 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations
Medical
- MedlinePlus Health Information